Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial (Q42252095)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 August 2013
edit
Language Label Description Also known as
English
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial
scientific article published on 6 August 2013

    Statements

    Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial (English)
    Yan-Ping Li
    Zheng-Lun Liang
    Jie-Lai Xia
    Jun-Yu Wu
    Ling Wang
    Li-Fei Song
    Qun-Ying Mao
    Shu-Qun Wen
    Ren-Guo Huang
    Yuan-Sheng Hu
    Rong-Cheng Li
    Jun-Zhi Wang
    Wei-Dong Yin
    6 August 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit